WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2006017075) PROGESTERONE RECEPTOR ANTAGONIST CONTRACEPTIVE REGIMENS AND KITS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2006/017075 International Application No.: PCT/US2005/023798
Publication Date: 16.02.2006 International Filing Date: 06.07.2005
IPC:
A61K 31/404 (2006.01) ,A61K 31/536 (2006.01) ,A61K 31/537 (2006.01) ,A61P 15/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403
condensed with carbocyclic rings, e.g. carbazole
404
Indoles, e.g. pindolol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
536
ortho- or peri-condensed with carbocyclic ring systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
537
spiro-condensed or forming part of bridged ring systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15
Drugs for genital or sexual disorders; Contraceptives
18
Feminine contraceptives
Applicants: GRUBB, Gary, Sondermann[US/US]; US (UsOnly)
CONSTANTINE, Ginger, Dale[US/US]; US (UsOnly)
FENSOME, Andrew[GB/US]; US (UsOnly)
MCCOMAS, Casey, Cameron[US/US]; US (UsOnly)
MELENSKI, Edward, George[US/US]; US (UsOnly)
MARELLA, Michael, Anthony[US/US]; US (UsOnly)
WROBEL, Jay, Edward[US/US]; US (UsOnly)
WYETH[US/US]; Five Giralda Farms Madison, NJ 07940, US (AllExceptUS)
Inventors: GRUBB, Gary, Sondermann; US
CONSTANTINE, Ginger, Dale; US
FENSOME, Andrew; US
MCCOMAS, Casey, Cameron; US
MELENSKI, Edward, George; US
MARELLA, Michael, Anthony; US
WROBEL, Jay, Edward; US
Agent: KODROFF, Cathy, A.; Howson and Howson 321 Norristown Road, Suite 200 Spring House Corporate Center P.O. Box 457 Spring House, PA 19477 , US
Priority Data:
60/585,88307.07.2004US
60/676,13529.04.2005US
Title (EN) PROGESTERONE RECEPTOR ANTAGONIST CONTRACEPTIVE REGIMENS AND KITS
(FR) REGIMES ET KITS CONTRACEPTIFS D'ANTAGONISTE DE RECEPTEUR DE PROGESTERONE
Abstract:
(EN) A method of contraception is provided which involves delivery of 21 to 27 consecutive days of one or more PR antagonists in the absence of a progestin, estrogen, or other steroidal compound, followed by 1 to 7 days without any active agent. Also described is a pharmaceutically useful kit to facilitate delivery of this regimen.
(FR) La présente invention concerne un procédé de contraception qui met en œuvre la prise pendant 21 à 27 jours consécutifs d'un ou plusieurs antagonistes de PR en l'absence de progestine, d'estrogène ou d'autre composé stéroïde, suivie par 1 à 7 jours sans aucun agent actif. Il est décrit en outre un kit pharmaceutiquement utile pour faciliter la prise de ce régime.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)